HRZN.NASDAQHorizon Technology Finance CORP
10-Q: Horizon Technology Finance Corp Reports Q3 2024 Results, Net Assets Decline
Sentiment:
Quarterly Report
Horizon Technology Finance Corp's Q3 2024 results show a decrease in net assets and a shift in investment income.
Capital raiseThe company sold 1,709,096 shares of common stock under the 2023 Equity Distribution Agreement for net proceeds of approximately $18.4 million during the three months ended September 30, 2024.The company sold 4,279,141 shares of common stock under the 2023 Equity Distribution Agreement for net proceeds of approximately $47.5 million during the nine months ended September 30, 2024.The company entered into a note purchase agreement in connection with the issuance and sale of $20,000,000 aggregate principal of the Company's 7.125% Convertible Notes due 2031.
Worse than expectedThe company's net investment income decreased compared to the same period last year.The company experienced a net realized loss on investments.The company's net asset value per common share decreased.
Summary
- Horizon Technology Finance Corporation reported a net decrease in net assets resulting from operations of $7.3 million for the three months ended September 30, 2024, compared to a net decrease of $12.0 million for the same period in 2023.
- Net investment income was $11.8 million for the quarter, down from $17.4 million in the prior year.
- The company experienced a net realized loss on investments of $33.9 million and a net unrealized appreciation on investments of $29.3 million for the quarter.
- Total investment income decreased to $24.6 million from $29.1 million year-over-year.
- The company's net asset value per common share decreased to $9.06 from $9.71 at the end of the previous quarter.
- The company's total assets decreased from $802.4 million at December 31, 2023 to $793.1 million at September 30, 2024.
- The company's total liabilities decreased from $478.4 million at December 31, 2023 to $450.5 million at September 30, 2024.
- The company's total net assets increased from $324.0 million at December 31, 2023 to $342.5 million at September 30, 2024.
Sentiment
Score: 4
Explanation: The document presents a mixed picture with decreased net investment income and net asset value, but also an increase in total net assets. The negative aspects outweigh the positives, leading to a slightly negative sentiment.
Positives
- The company's total net assets increased from $324.0 million at December 31, 2023 to $342.5 million at September 30, 2024.
- The company's total liabilities decreased from $478.4 million at December 31, 2023 to $450.5 million at September 30, 2024.
Negatives
- Net investment income decreased to $11.8 million for the three months ended September 30, 2024, compared to $17.4 million for the same period in 2023.
- The company experienced a net realized loss on investments of $33.9 million for the quarter.
- Total investment income decreased to $24.6 million from $29.1 million year-over-year.
- The company's net asset value per common share decreased to $9.06 from $9.71 at the end of the previous quarter.
- The company's total assets decreased from $802.4 million at December 31, 2023 to $793.1 million at September 30, 2024.
Risks
- The company's investments are primarily in development-stage companies, which may have limited operating histories and may experience variation in operating results.
- Many of the company's borrowers may need additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the loans.
- The company's largest debt investments may vary from period to period as new debt investments are recorded and existing debt investments are repaid.
- The company is subject to financial market risks, including changes in interest rates.
- Persistent inflationary pressures could affect the company's portfolio companies profit margins.
Future Outlook
The company expects to raise additional equity and debt capital opportunistically as needed and, subject to market conditions, to support its future growth to the extent permitted by the 1940 Act. The company believes that its current cash, cash generated from operations, and funds available from its Credit Facilities will be sufficient to meet its working capital and capital expenditure commitments for at least the next 12 months.
Industry Context
The company operates in the specialty finance sector, focusing on venture lending to development-stage companies in technology, life science, healthcare information and services, and sustainability industries. The company's performance is influenced by the overall economic environment, interest rate fluctuations, and the success of its portfolio companies in these sectors.
Comparison to Industry Standards
- The company's performance is compared to other Business Development Companies (BDCs) that focus on venture lending.
- The company's net investment income and net asset value per share are key metrics used to assess its performance against industry benchmarks.
- The company's portfolio composition, including the mix of debt and equity investments, is compared to industry standards.
- The company's credit quality ratings and non-accrual rates are compared to industry averages to assess its risk management practices.
- The company's use of leverage and its compliance with regulatory requirements are compared to industry standards for BDCs.
Related Party Transactions
- The company has entered into an Investment Management Agreement with its Advisor, Horizon Technology Finance Management LLC, under which the Advisor manages the day-to-day operations of, and provides investment advisory services to, the Company.
- The company has also entered into an Administration Agreement with its Advisor under which the company has agreed to reimburse its Advisor for the company's allocable portion of overhead and other expenses incurred by the Advisor in performing its obligations under the Administration Agreement.
Stakeholder Impact
- Shareholders may experience a decrease in net asset value per share.
- Shareholders may experience a decrease in distributions.
- Portfolio companies may face challenges due to the difficult equity fundraising market and underperformance of certain portfolio companies.
- Lenders may be impacted by changes in interest rates and the company's credit quality.
Next Steps
- The company expects to raise additional equity and debt capital opportunistically as needed.
- The company will continue to monitor its portfolio companies and manage its credit risk.
- The company will continue to evaluate its investment strategy and make adjustments as necessary.
Key Dates
| Date | Description |
|---|---|
| 2010-03-16 | Horizon Technology Finance Corporation was organized as a Delaware corporation. |
| 2010-10-28 | The Company completed an initial public offering (IPO). |
| 2011-06-28 | Horizon Credit II LLC (Credit II) was formed as a Delaware limited liability company. |
| 2013-11-04 | The Company entered into the Key Facility with KeyBank National Association. |
| 2018-05-09 | Horizon Funding I, LLC (HFI) was formed as a Delaware limited liability company. |
| 2019-05-02 | The Company formed Horizon Funding 20191 LLC (20191 LLC) as a Delaware limited liability company. |
| 2019-05-15 | The Company formed Horizon Funding Trust 20191 as a Delaware statutory trust. |
| 2019-08-13 | The Company completed a term debt securitization in connection with which an affiliate of the Company made an offering of the 2019 Asset-Backed Notes. |
| 2020-04-21 | As of this date, HSLFI and its subsidiary, HFI, are consolidated in the financial statements of the Company. |
| 2021-03-30 | The Company issued and sold an aggregate principal amount of $57.5 million of 4.875% notes due in 2026 (the 2026 Notes). |
| 2021-08-02 | The Company entered into an At-The-Market (ATM) sales agreement (the 2021 Equity Distribution Agreement). |
| 2022-06-15 | The Company issued and sold an aggregate principal amount of $50.0 million of 6.25% notes due in 2027 (the 2027 Notes). |
| 2022-07-11 | The Company sold an additional $7.5 million of the 2027 Notes. |
| 2022-07-29 | The Company's board of directors (the Board) designated the Advisor as the Company's valuation designee. |
| 2022-09-30 | The Company formed Horizon Funding 20221 LLC (20221 LLC) as a Delaware limited liability company. |
| 2022-10-18 | The Company formed Horizon Funding Trust 20221 as a Delaware statutory trust. |
| 2022-11-09 | The Company completed a term debt securitization in connection with which an affiliate of the Company made an offering of the 2022 Asset-Backed Notes. |
| 2023-05-24 | The Company amended its NYL Facility to, among other things, increase the commitment by $50.0 million. |
| 2023-06-02 | The Company completed a follow-on public offering of 3,250,000 shares of common stock. |
| 2023-06-29 | The Company amended the Key Facility, among other things, to increase the commitment amount to $150 million. |
| 2023-06-30 | The new Investment Management Agreement became effective. |
| 2023-09-22 | The Company terminated the 2021 Equity Distribution Agreement and entered into a new ATM sales agreement (the 2023 Equity Distribution Agreement). |
| 2024-04-26 | The Board extended a previously authorized stock repurchase program. |
| 2024-05-06 | The Company amended its NYL Facility to, among other things, extend the investment period to June 2025 and the maturity date of all advances to June 2030. |
| 2024-05-13 | Horizon Funding II, LLC (HFII) was formed as a Delaware limited liability company. |
| 2024-06-20 | The Company amended the Key Facility, among other things, to extend the date on which the Company may request advances under the Key Facility to June 20, 2027 and to extend the maturity date to June 20, 2029. |
| 2024-06-21 | The Company sold or contributed to HFII certain secured loans made to certain portfolio companies pursuant to the Sale and Servicing Agreement. |
| 2024-10-07 | The Company funded a $2.5 million debt investment to an existing portfolio company, Standvast Holdings, LLC. |
| 2024-10-15 | The Company funded a $0.6 million debt investment to an existing portfolio company, Swift Health Systems, Inc. |
| 2024-10-17 | The Company entered into a note purchase agreement in connection with the issuance and sale of $20,000,000 aggregate principal of the Company's 7.125% Convertible Notes due 2031. |
| 2024-10-18 | The Company funded a $0.5 million debt investment to an existing portfolio company, Better Place Forests Co. |
| 2024-10-23 | CAMP NYC, Inc. (CAMP) prepaid its outstanding principal balance of $2.0 million on its venture loan. |
| 2024-10-25 | The Board declared monthly distributions per share. |
Keywords
Venture Lending, Debt Investments, Technology, Life Science, Healthcare, Sustainability, Business Development Company, BDC, Net Asset Value, Warrants, Credit Risk, Interest Rate Risk
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.